JCO global oncologyHumansMaleFemaleAdultHepatitis B
Risk of Hepatitis B Reactivation Among ALL Patients With Occult Hepatitis B Infection.
Hasmukh Jain, Neha Sharma, Devanshee Shah, Thomas Eipe, Netra Ghandade, Jayashree Thorat, Bhausaheb Bagal, Lingaraj Nayak, Alok Shetty, Anupa John, Sanjay K Biswas, Gaurav Salunkhe, Sridhar Sundaram, Prachi S Patil, Manju Sengar
Published: 202610.1200/GO-25-00262
Abstract
PURPOSE: Anticancer therapy increases the risk of hepatitis B virus (HBV) reactivation in patients with occult hepatitis B infection (OHBI), particularly in those who receive rituximab or stem-cell transplantation. However, the exact risk of HBV reac…
Preview only. Read the full abstract at the source